Last reviewed · How we verify
RLS-1496 1.0% cream
At a glance
| Generic name | RLS-1496 1.0% cream |
|---|---|
| Sponsor | Rubedo Life Sciences, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluate RLS-1496 Topical Cream for Actinic Keratosis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RLS-1496 1.0% cream CI brief — competitive landscape report
- RLS-1496 1.0% cream updates RSS · CI watch RSS
- Rubedo Life Sciences, Inc. portfolio CI